News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,843 Results
Type
Article (41974)
Company Profile (328)
Press Release (686530)
Multimedia
Podcasts (90)
Webinars (17)
Section
Business (206480)
Career Advice (2057)
Deals (35763)
Drug Delivery (112)
Drug Development (81779)
Employer Resources (174)
FDA (16537)
Job Trends (15072)
News (348999)
Policy (32939)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2621)
Accelerated approval (31)
Adcomms (25)
Allergies (141)
Alliances (50289)
ALS (171)
Alzheimer's disease (1681)
Antibody-drug conjugate (ADC) (314)
Approvals (16803)
Artificial intelligence (532)
Autoimmune disease (153)
Automation (39)
Bankruptcy (364)
Best Places to Work (11721)
BIOSECURE Act (21)
Biosimilars (190)
Biotechnology (216)
Bladder cancer (159)
Brain cancer (57)
Breast cancer (646)
Cancer (4848)
Cardiovascular disease (405)
Career advice (1737)
Career pathing (36)
CAR-T (287)
CDC (45)
Celiac Disease (2)
Cell therapy (755)
Cervical cancer (36)
Clinical research (69821)
Collaboration (1749)
Company closure (4)
Compensation (1153)
Complete response letters (53)
COVID-19 (2739)
CRISPR (92)
C-suite (852)
Cystic fibrosis (145)
Data (6235)
Decentralized trials (2)
Denatured (31)
Depression (136)
Diabetes (501)
Diagnostics (6812)
Digital health (48)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (187)
Drug shortages (29)
Duchenne muscular dystrophy (231)
Earnings (90436)
Editorial (56)
Employer branding (21)
Employer resources (154)
Events (118630)
Executive appointments (991)
FDA (19675)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1489)
Gene editing (202)
Generative AI (45)
Gene therapy (605)
GLP-1 (977)
Government (4689)
Grass and pollen (6)
Guidances (384)
Healthcare (19057)
HIV (59)
Huntington's disease (45)
IgA nephropathy (81)
Immunology and inflammation (258)
Immuno-oncology (60)
Indications (108)
Infectious disease (3007)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (116)
Intellectual property (249)
Interviews (319)
IPO (16717)
IRA (51)
Job creations (3690)
Job search strategy (1454)
JPM (58)
Kidney cancer (15)
Labor market (84)
Layoffs (558)
Leadership (31)
Legal (7991)
Liver cancer (92)
Longevity (14)
Lung cancer (649)
Lymphoma (376)
Machine learning (43)
Management (60)
Manufacturing (802)
MASH (165)
Medical device (13888)
Medtech (13941)
Mergers & acquisitions (20118)
Metabolic disorders (1273)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (321)
Neuropsychiatric disorders (89)
Neuroscience (2925)
Neurotech (1)
NextGen: Class of 2026 (6615)
Non-profit (4556)
Now hiring (67)
Obesity (597)
Opinion (265)
Ovarian cancer (167)
Pain (199)
Pancreatic cancer (226)
Parkinson's disease (283)
Partnered (35)
Patents (492)
Patient recruitment (489)
Peanut (56)
People (59475)
Pharmaceutical (69)
Pharmacy benefit managers (29)
Phase 1 (21809)
Phase 2 (30727)
Phase 3 (22867)
Pipeline (5240)
Policy (282)
Postmarket research (2568)
Preclinical (9274)
Press Release (66)
Prostate cancer (240)
Psychedelics (48)
Radiopharmaceuticals (281)
Rare diseases (838)
Real estate (6026)
Recruiting (70)
Regulatory (24644)
Reports (52)
Research institute (2442)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (19)
RSV (76)
Schizophrenia (147)
Series A (248)
Series B (195)
Service/supplier (13)
Sickle cell disease (99)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3699)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (85)
The Weekly (57)
Vaccines (1003)
Venture capital (89)
Weight loss (385)
Women's health (89)
Worklife (18)
Date
Today (130)
Last 7 days (619)
Last 30 days (2113)
Last 365 days (30347)
2026 (3220)
2025 (30658)
2024 (35630)
2023 (40515)
2022 (51616)
2021 (56174)
2020 (54473)
2019 (46961)
2018 (35335)
2017 (32469)
2016 (31878)
2015 (37933)
2014 (31620)
2013 (26680)
2012 (28932)
2011 (29565)
2010 (27632)
Location
Africa (747)
Alabama (83)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (39730)
Australia (6502)
California (11369)
Canada (3281)
China (1111)
Colorado (484)
Connecticut (480)
Delaware (333)
Europe (86155)
Florida (1684)
Georgia (359)
Hawaii (3)
Idaho (62)
Illinois (861)
India (65)
Indiana (521)
Iowa (22)
Japan (427)
Kansas (127)
Kentucky (39)
Louisiana (27)
Maine (72)
Maryland (1390)
Massachusetts (8181)
Michigan (323)
Minnesota (632)
Mississippi (5)
Missouri (137)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (2997)
New Mexico (29)
New York (2990)
North Carolina (1457)
North Dakota (8)
Northern California (5538)
Ohio (337)
Oklahoma (22)
Oregon (42)
Pennsylvania (2278)
Puerto Rico (25)
Rhode Island (47)
South America (1120)
South Carolina (66)
South Dakota (1)
Southern California (4421)
Tennessee (177)
Texas (1763)
United States (40279)
Utah (338)
Vermont (1)
Virginia (267)
Washington D.C. (82)
Washington State (940)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
728,843 Results for "precision biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio
January 12, 2026
·
8 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
January 7, 2026
·
4 min read
Press Releases
Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy
February 11, 2026
·
9 min read
Press Releases
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
January 12, 2026
·
3 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
January 7, 2026
·
4 min read
Press Releases
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - December 23, 2025
December 24, 2025
·
1 min read
Press Releases
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
February 10, 2026
·
4 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - February 9, 2026
February 10, 2026
·
1 min read
Press Releases
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025
October 31, 2025
·
1 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 5, 2026
·
1 min read
1 of 72,885
Next
